|
CETP TaqI B and D442G polymorphisms: allele and genotype frequencies in T2DM patients and controls |
||||
| Patient* n (%) |
Control* n (%) |
P-value |
OR (95% CI) |
|
|
|
||||
| B1B1 |
40 (29.41) |
72 (27.27) |
0.652 |
1.11 (0.70–1.76) |
| B1B2 |
73 (53.68) |
134 (50.76) |
0.580 |
1.12 (0.74–1.70) |
| B2B2 |
23 (16.91) |
58 (21.97) |
0.233 |
0.72 (0.42–1.23) |
| B1 |
153 (56.25) |
278 (52.65) |
0.333 |
1.16 (0.86–1.55) |
| B2 |
119 (43.75) |
250 (47.35) |
0.333 |
0.87 (0.64–1.16) |
| DD |
136 (100) |
264 (100) |
- |
- |
| GG |
0 (0) |
0 (0) |
- |
- |
|
* Total T2DM patients 136 and controls 264 | ||||
Dixit et al. BMC Endocrine Disorders 2005 5:7 doi:10.1186/1472-6823-5-7 |
||||